Trial site
Memorial Sloan Kettering Nassau (Limited Protocol Activities)
- 92running trials
- 12closed trials
The trials here
What the 104 trials at this site are about, from their registry records.
- Conditions
- Multiple myeloma14 trials
- Lung cancer11 trials
- Head and neck cancer8 trials
- Ovarian cancer8 trials
- Prostate cancer8 trials
- Bladder cancer7 trials
- Metastatic breast cancer7 trials
- Sarcoma7 trials
- Childhood cancers6 trials
- Kidney cancer4 trials
- Melanoma4 trials
- Colorectal cancer3 trials
- and 22 more
- Phase
- Phase 259 trials
- Phase 117 trials
- Phase 1/212 trials
- Early phase 12 trials
- Phase 32 trials
- Status
- Recruiting52 trials
- Active, not recruiting39 trials
- Completed10 trials
- Not yet recruiting1 trial
- Terminated1 trial
- Withdrawn1 trial
- Lead sponsor
- Memorial Sloan Kettering Cancer Center103 trials
- City of Hope Medical Center1 trial
Running trials
Not yet recruiting
A Study of Zanubrutinib, Obinutuzumab, and Sonrotoclax in People With Mantle Cell Lymphoma
Recruiting
A Study of Ropeg-Interferon in People With Polycythemia Vera
Recruiting
Recruiting
A Study of Romosozumab in People With Breast Cancer and Osteoporosis
Recruiting
Recruiting
Recruiting
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
Recruiting
A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia
Recruiting
Recruiting
Recruiting
Recruiting
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
Recruiting
Recruiting
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
Recruiting
Recruiting
A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer
Recruiting
Recruiting
A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma
Recruiting
A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)
Recruiting
A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell Carcinoma
Recruiting
A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer
Recruiting
A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis
Recruiting
Recruiting
Recruiting
A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma
Recruiting
Recruiting
Recruiting
Recruiting
A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer
Recruiting
A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia
Recruiting
A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer
Recruiting
Recruiting
A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)
Recruiting
Recruiting
A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer
Active, not recruiting
A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer
Active, not recruiting
Recruiting
Recruiting
Recruiting
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
Recruiting
A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
Active, not recruiting
A Study of IO102/IO103, Nivolumab, and Relatlimab in People With Melanoma
Active, not recruiting
A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract
Recruiting
A Study to Prevent and Improve Sexual Health Concerns for People With Breast Cancer
Active, not recruiting
A Study of Tucatinib Given Before Surgery to People With HER2+ Cancers That Have Spread to the Brain
Recruiting
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
Active, not recruiting
Showing 50 of 92.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer7 recruiting
- Multiple myeloma7 recruiting
- Head and neck cancer5 recruiting
- Ovarian cancer5 recruiting
- Childhood cancers4 recruiting
- Sarcoma4 recruiting
- Metastatic breast cancer3 recruiting
- Myeloproliferative neoplasms3 recruiting
- Acute lymphoblastic leukaemia2 recruiting
- Colorectal cancer2 recruiting
- Gastric and oesophageal cancer2 recruiting
- Kidney cancer2 recruiting
- Melanoma2 recruiting
- Mesothelioma2 recruiting
- Prostate cancer2 recruiting
- Acute myeloid leukaemia1 recruiting
- Bladder cancer1 recruiting
- Chronic kidney disease1 recruiting
- Cushing's syndrome1 recruiting
- Endometrial cancer1 recruiting
- Glioblastoma1 recruiting
- Liver and biliary tract cancer1 recruiting
- Mantle cell lymphoma1 recruiting
- Osteoporosis1 recruiting
- Pituitary tumours1 recruiting
Closed trials
Withdrawn
A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer
Completed
A Study of Local Ablative Therapy (LAT) in People With Non-Small Cell Lung Cancer (NSCLC)
Completed
Completed
A Study of Pembrolizumab and Cryoablation in People With Mesothelioma
Completed
Exercise Therapy in Cancer Patients Who Are Recovering From COVID-19
Completed
Completed
Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer
Completed
Talazoparib and Avelumab in Participants With Metastatic Renal Cell Carcinoma
Completed
Nivolumab and Ipilimumab in People With Aggressive Pituitary Tumors
Terminated
A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer
Completed
Completed
Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers
Site data: ClinicalTrials.govUpdated 17 Nov 2026